PTPRB and autoimmune disease: Therapeutically, PtpB-MIP demonstrates dual anti-inflammatory and immunoregulatory properties, positioning it as a promising candidate for managing inflammatory and autoimmune disorders, contrasting with strategies targeting PtpB-Mtb inhibition to restore antimicrobial defenses [23].